A detailed history of Ostrum Asset Management transactions in Viatris Inc stock. As of the latest transaction made, Ostrum Asset Management holds 138,203 shares of VTRS stock, worth $1.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
138,203
Previous 190,357 27.4%
Holding current value
$1.6 Million
Previous $2.27 Billion 35.36%
% of portfolio
0.13%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.05 - $12.02 $524,147 - $626,891
-52,154 Reduced 27.4%
138,203 $1.47 Billion
Q4 2023

Feb 13, 2024

BUY
$8.77 - $10.85 $7,024 - $8,690
801 Added 0.42%
190,357 $2.06 Billion
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $1.71 Million - $2.02 Million
178,399 Added 1598.99%
189,556 $1.87 Billion
Q2 2023

Aug 11, 2023

BUY
$9.02 - $10.29 $99 - $113
11 Added 0.1%
11,157 $111 Million
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $102,543 - $136,649
11,146 New
11,146 $107 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Ostrum Asset Management Portfolio

Follow Ostrum Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ostrum Asset Management with notifications on news.